BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 32341496)

  • 1. Repositioning of antiarrhythmics for prostate cancer treatment: a novel strategy to reprogram cancer-associated fibroblasts towards a tumor-suppressive phenotype.
    Doldi V; Tortoreto M; Colecchia M; Maffezzini M; Percio S; Giammello F; Brandalise F; Gandellini P; Zaffaroni N
    J Exp Clin Cancer Res; 2024 Jun; 43(1):161. PubMed ID: 38858661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of ORAOV1 as a new treatment target in hepatocellular carcinoma.
    Ha SY; Yeo SY; Lee KW; Kim SH
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):423-433. PubMed ID: 33161447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive exploration of twist1 to identify a biomarker for tumor immunity and prognosis in pan-cancer.
    Wang Y; Li C; Jiang T; Yin Y; Wang Y; Zhao H; Yu L
    Medicine (Baltimore); 2024 Apr; 103(15):e37790. PubMed ID: 38608058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PROX1 interaction with α-SMA-rich cancer-associated fibroblasts facilitates colorectal cancer progression and correlates with poor clinical outcomes and therapeutic resistance.
    Lai SW; Cheng YC; Kiu KT; Yen MH; Chen YW; Yadav VK; Yeh CT; Kuo KT; Chang TC
    Aging (Albany NY); 2024 Jan; 16(2):1620-1639. PubMed ID: 38244581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PRRX1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression.
    Lee KW; Yeo SY; Gong JR; Koo OJ; Sohn I; Lee WY; Kim HC; Yun SH; Cho YB; Choi MA; An S; Kim J; Sung CO; Cho KH; Kim SH
    Nat Commun; 2022 May; 13(1):2793. PubMed ID: 35589735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New screening system using Twist1 promoter activity identifies dihydrorotenone as a potent drug targeting cancer-associated fibroblasts.
    Lee E; Yeo SY; Lee KW; Lee JA; Kim KK; Kim SH
    Sci Rep; 2020 Apr; 10(1):7058. PubMed ID: 32341496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts.
    Moatassim-Billah S; Duluc C; Samain R; Jean C; Perraud A; Decaup E; Cassant-Sourdy S; Bakri Y; Selves J; Schmid H; Martineau Y; Mathonnet M; Pyronnet S; Bousquet C
    Oncotarget; 2016 Jul; 7(27):41584-41598. PubMed ID: 27177087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual role of twist1 in cancer-associated fibroblasts and tumor cells promoted epithelial-mesenchymal transition of esophageal cancer.
    Zhu X; Han S; Wu S; Bai Y; Zhang N; Wei L
    Exp Cell Res; 2019 Feb; 375(2):41-50. PubMed ID: 30611739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twist1 is up-regulated in gastric cancer-associated fibroblasts with poor clinical outcomes.
    Sung CO; Lee KW; Han S; Kim SH
    Am J Pathol; 2011 Oct; 179(4):1827-38. PubMed ID: 21854747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twist1-induced activation of human fibroblasts promotes matrix stiffness by upregulating palladin and collagen α1(VI).
    García-Palmero I; Torres S; Bartolomé RA; Peláez-García A; Larriba MJ; Lopez-Lucendo M; Peña C; Escudero-Paniagua B; Muñoz A; Casal JI
    Oncogene; 2016 Oct; 35(40):5224-5236. PubMed ID: 26973246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAA1 is upregulated in gastric cancer-associated fibroblasts possibly by its enhancer activation.
    Yasukawa Y; Hattori N; Iida N; Takeshima H; Maeda M; Kiyono T; Sekine S; Seto Y; Ushijima T
    Carcinogenesis; 2021 Feb; 42(2):180-189. PubMed ID: 33284950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A positive feedback loop bi-stably activates fibroblasts.
    Yeo SY; Lee KW; Shin D; An S; Cho KH; Kim SH
    Nat Commun; 2018 Aug; 9(1):3016. PubMed ID: 30069061
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.